Revive Therapeutics Ltd (RVVTF)

[alabama1man]

Partly because of a lack of data - those organizations (in my opinion) see no real push to get the trial done (whether for lack of funding or any other reason) by a small company for an existing drug that is actually not even approved for use (from what I can see) in most of the world - I just don't think it's visible on their radar as anything more than a small company trying to break into a market. With the multitude of 'possible' other treatments, we'll have to do better than take over a year to get around 1000 test cases.

We really need the study unblinded (for better or worse) and reviewed. Whatever we have at 700 is statistically most likely what we will have at 1000. I'm not sure if the data isn't convincing enough and they're hoping it gets better or they feel they don't have enough statistical information.

The (what I'll call) add-ons that were recently being looked at, could be done with the trial unblinded.

Don't forget that while we feel we have THE solution, the organizations you mentioned are inundated and want to know results - not possibilities.

I'm still extremely hopeful, but I think the clock is getting close to midnight.